Sanofi (SNY) EPS (Basic) Growth (5y) (2014 - 2026)
Sanofi (SNY) EPS (Basic) Growth (5y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Gsk |
92,134,969.93 Bn |
92,134,964.97 Bn |
7.76 Bn |
| 2 |
Eli Lilly |
1,027.45 Bn |
1,022.17 Bn |
16.22 Bn |
| 3 |
Johnson & Johnson |
559.08 Bn |
537.03 Bn |
15.96 Bn |
| 4 |
AbbVie |
394.75 Bn |
385.40 Bn |
10.78 Bn |
| 5 |
Merck |
295.12 Bn |
289.47 Bn |
12.09 Bn |
| 6 |
Amgen |
186.65 Bn |
174.61 Bn |
5.87 Bn |
| 7 |
Gilead Sciences |
159.22 Bn |
151.50 Bn |
5.52 Bn |
| 8 |
Pfizer |
146.00 Bn |
133.23 Bn |
-1.21 Bn |
| 9 |
Bristol Myers Squibb |
113.22 Bn |
102.77 Bn |
8.07 Bn |
| 10 |
Sanofi |
61.90 Mn |
-6.87 Bn |
9.49 Bn |
| Date | Value |
|---|
| Mar 31, 2026 |
60.17% |
| Dec 31, 2025 |
-16.21% |
| Sep 30, 2025 |
229.66% |
| Mar 31, 2025 |
153.22% |
| Dec 31, 2024 |
-14.87% |
| Sep 30, 2024 |
64.47% |
| Jun 30, 2024 |
17.93% |
| Mar 31, 2024 |
193.72% |
| Dec 31, 2023 |
-28.77% |
| Sep 30, 2023 |
12.06% |
| Jun 30, 2023 |
0.51% |
| Mar 31, 2023 |
15.79% |
| Dec 31, 2022 |
365.84% |
| Sep 30, 2022 |
17.60% |
| Jun 30, 2022 |
15.06% |
| Mar 31, 2022 |
5.78% |
| Dec 31, 2021 |
-35.57% |
| Sep 30, 2021 |
4.22% |
| Jun 30, 2021 |
-4.92% |
| Mar 31, 2021 |
13.52% |
